5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE
![5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE price.](/StructureFile/ChemBookStructure5/GIF/CB1429183.gif)
|
- $75 - $451
- Product name: 5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE
- CAS: 387824-55-7
- MF: C10H6F3NO
- MW: 213.16
- EINECS:
- MDL Number:MFCD02183551
- Synonyms:BUTTPARK 32\03-45;5-[4-(TRIFLUOROMETHYL)PHENYL]ISOXAZOLE;5-[4-(Trifluoromethyl)phenyl]isoxazole97%;Isoxazole, 5-[4-(trifluoromethyl)phenyl]-
4 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
- TRC
Package
- 100mg
- 1g
- 10g
- ManufacturerAK Scientific
- Product number2283AE
- Product description5-[4-(Trifluoromethyl)phenyl]isoxazole
- Packaging1g
- Price$198
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11131189
- Product description5-(4-(Trifluoromethyl)phenyl)isoxazole 97%
- Packaging10g
- Price$451
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number007041
- Product description5-[4-(Trifluoromethyl)phenyl]isoxazole
- Packaging1g
- Price$110
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberT900065
- Product description5-[4-(Trifluoromethyl)phenyl]isoxazole
- Packaging100mg
- Price$75
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 2283AE | 5-[4-(Trifluoromethyl)phenyl]isoxazole | 1g | $198 | 2021-12-16 | Buy |
| Crysdot | CD11131189 | 5-(4-(Trifluoromethyl)phenyl)isoxazole 97% | 10g | $451 | 2021-12-16 | Buy |
| Matrix Scientific | 007041 | 5-[4-(Trifluoromethyl)phenyl]isoxazole | 1g | $110 | 2021-12-16 | Buy |
| TRC | T900065 | 5-[4-(Trifluoromethyl)phenyl]isoxazole | 100mg | $75 | 2021-12-16 | Buy |
Properties
Boiling point :266.8±35.0 °C(Predicted)
Density :1.297±0.06 g/cm3(Predicted)
pka :-3.33±0.10(Predicted)
Density :1.297±0.06 g/cm3(Predicted)
pka :-3.33±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|